Ignite Creation Date:
2024-05-05 @ 12:09 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00259402
Status:
COMPLETED
Last Update Posted:
2009-12-07
First Post:
2005-11-28
Brief Title:
Oxaliplatin in Esophagus Cancer Advanced 1st Line
Sponsor:
Sanofi
Organization:
Sanofi
Study Overview
Official Title:
Phase II Open-label Single Arm Study of Oxaliplatin Combined With Cisplatin and 5FU in Advanced Esophagus Cancer Patients
Status:
COMPLETED
Status Verified Date:
2009-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To determine the activity and efficacy of the schema specified as dose regimen
To determine the safety and tolerability of the oxaliplatin-cisplatin and 5FU
To determine the safety and tolerability of the oxaliplatin-cisplatin and 5FU
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None